血汗管药物和医治 SCIE

期刊简介估计审稿时候： 约4.5月

Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

《血汗管药物与医治》旨在客观地报道血汗管药物、装备和细胞疗法从尝试室光临床的开辟进程，以实时且有用的情势为您供给最须要的信息，它以全新且布满活气的视角对待这一静态范畴的停顿。

《血汗管药物与医治》存眷最使人高兴的新型医治药物研讨，重点存眷动脉粥样软化、高脂血症、糖尿病、缺血综合征和心律变态的成长。该期刊是以后和相干信息的权势巨子来历，对追求新奇、冲破性研讨的根本和临床研讨职员和追求为患者供给最好办事的心脏病专家来讲，这些信息都是必不可少的。

《血汗管药物与医治》为您供给一个简要简要的参考东西，被公以为天下上最好的参考东西之一，被收录在 Web of Science 和 PubMed/Medline 等文摘和索引办事中。按期的文章和频仍的专题专题为您供给了最新的信息来历，这些信息是针对不时成长的范畴瞄切确信息的须要而界说的。《血汗管药物和医治》是一本详尽而切确的指南，带您穿梭新产物和疗法的迷宫，为您供给有关血汗管药理学的具体信息，您将一次又一次地参考这些信息。

《Cardiovascular Drugs And Therapy》(血汗管药物和医治)编辑部通信体例为SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。